Valuation: CARMAT

Market Cap 61.46L 70.28L 56.49L 52.65L 99.82L 67Cr 1.01Cr 6.77Cr 2.64Cr 33Cr 2.64Cr 2.58Cr 113.48Cr P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 5.92Cr 6.78Cr 5.45Cr 5.08Cr 9.62Cr 645.24Cr 9.77Cr 65Cr 25Cr 317.15Cr 25Cr 25Cr 1.09TCr EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 55 01/09/2016
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/04/2025
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 02/01/2017
Director/Board Member 79 20/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%-.--% - - 70.8L
+4.20%-1.85%-17.39%+9.58% 13TCr
+0.04%-1.01%+1.39%-6.08% 1.28TCr
+7.83%+2.71%+43.32%+112.86% 870.84Cr
+2.29%+7.17%-46.92%-72.29% 406.91Cr
+4.16%+8.39%+25.37%+43.89% 273.22Cr
+2.53%+23.07%-7.66%-13.04% 188.81Cr
+3.55%+8.85%-0.99%-23.29% 166.81Cr
-5.25%-5.89%+179.33%+133.76% 146.42Cr
Average +2.09%+1.23%+22.06%+23.17% 1.98TCr
Weighted average by Cap. +3.90%+2.90%-10.46%+13.01%

Financials

2023 2024
Net sales 38.37L 43.88L 35.27L 32.87L 62.32L 42Cr 63.25L 4.23Cr 1.65Cr 21Cr 1.65Cr 1.61Cr 71Cr 73.44L 83.98L 67.51L 62.91L 1.19Cr 80Cr 1.21Cr 8.09Cr 3.15Cr 39Cr 3.15Cr 3.08Cr 135.6Cr
Net income -5.39Cr -6.16Cr -4.95Cr -4.61Cr -8.75Cr -586.68Cr -8.88Cr -59Cr -23Cr -288.37Cr -23Cr -23Cr -994.64Cr -5.14Cr -5.88Cr -4.72Cr -4.4Cr -8.35Cr -559.74Cr -8.47Cr -57Cr -22Cr -275.13Cr -22Cr -22Cr -948.96Cr
Net Debt 4.96Cr 5.68Cr 4.56Cr 4.25Cr 8.06Cr 540.58Cr 8.18Cr 55Cr 21Cr 265.71Cr 21Cr 21Cr 916.48Cr 5.31Cr 6.07Cr 4.88Cr 4.55Cr 8.62Cr 578.31Cr 8.75Cr 59Cr 23Cr 284.26Cr 23Cr 22Cr 980.44Cr
Logo CARMAT
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
-